New Products & Services
Mountain View, CA-Percutaneous Systems' telescopic PercSys Accordion stone management device is a microcatheter equipped with a multi-fold film occlusion at the distal end. Once deployed, the occlusion conforms to and fills the ureter, preventing retrograde stone fragment migration into the kidney.
Stone management device facilitates lithotripsy Tx
For more information, visit http://www.PercSys.com/.
For more information, visit http://www.healthtronics.com/.
Transducer blends biplane, endfire prostate imaging
Wilmington, MA-The slim 8818 transrectal transducer from B-K Medical Systems combines simultaneous biplane and endfire imaging for taking precise biopsies in any part of the prostate. Users can switch between scanning views and can choose the plane in which to take a biopsy. A dual biopsy guide contains needle channels for both types of imaging so all biopsies can be taken during the same insertion. The endfire biopsy channel ensures the shortest distance to the prostate apex, preventing surrounding tissue damage. Features include high-resolution images, ergonomic design, disposable biopsy guides and sterile covers, compatibility with modern sterilization methods, additional tools for tissue harmonic imaging, contrast imaging, 3D and volume render mode, and compatibility with Pro Focus 2202 and Viking 2400 ultrasound scanners.
For more information, visit http://www.bkmed.com/.
Lap surgery camera system provides sharper images
For more information, visit http://www.smith-nephew.com/.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.
